Violation Tracker Individual Record
Company:Eli Lilly and Co.
Date:September 29, 2009
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Eli Lilly agreed to pay $25.1 million in settlement of allegations it deceptively marketed its drug Zyprexa for unapproved uses. There was a separate a multistate settlement of the same issue.
Level of Government:state
Action Type:agency action
Agency:Connecticut Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Indiana
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.